Obesity is a chronic, progressive disease, and in 2022, it affected nearly half of all adults worldwide, making it a global health crisis. This reinforces the importance of having sufficient, appropriate strategies available for healthcare professionals so they can optimize patient outcomes. Our series of micro learning activities will provide tips and tools for the implementation of key obesity interventions, including nutritional, physical, behavioral, and pharmacological approaches. Partner with your patients and recognize the importance of treating obesity like any other chronic condition.
Transforming Global Obesity Care: Empowering Clinicians With Comprehensive Strategies From Early Diagnosis to Patient-Centered Treatments
Breaking the Bias: Addressing Stigma in Obesity Care
Disclosure of Relevant Financial Relationships
In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.
Nasreen Alfaris, MD, MPH
Endocrinology Diabetes, Metabolism, and Obesity Medicine
Program Director of the Obesity Medicine Fellowship
Obesity, Endocrine, and Metabolism Center (OEMC)
King Fahad Medical City (KFMC)
Riyadh, Saudi ArabiaDr. Alfaris has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Consulting Fees: Eli Lilly, Novo Nordisk
Andreea Ciudin, MD, PhD
Endocrinology and Nutrition Department
Obesity Unit Coordinator
Associate Professor of Human Physiology
University Hospital Vall Hebron
Barcelona, SpainDr. Ciudin has no relevant relationships to disclose.
Marta Comas Martinez
Nutritionist
University Hospital Vall Hebron
Granollers, SpainDr. Comas Martinez has no relevant relationships to disclose.
Walmir Coutinho, MD
Professor of Endocrinology
Catholic University of Rio de Janeiro
Rio de Janeiro, BrazilDr. Coutinho has no relevant relationships to disclose.
Linong Ji, MD
Professor of Medicine
Peking University
Beijing, ChinaDr. Ji has no relevant relationships to disclose.
Rita Nawar, MD
Endocrinologist
Dubai, United Arab EmiratesDr. Nawar has no relevant relationships to disclose.
Donna H. Ryan, MD
Professor Emerita
Pennington Biomedical Research Center
Baton Rouge, LADr. Ryan has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Ownership Interests: Calibrate, Epitomee, Roman, Scientific Intake, Xeno Bioscience
Consulting Fees: Altimmune, Amgen, AstraZeneca, Biohaven, Boehringer Ingelheim, Calibrate, Carmot/Roche, CINRx, Currax, Epitomee, Fractyl, Gila, Lilly, Nestle, Novo Nordisk, Regeneron, Scientific Intake, Structure Therapeutics, Wondr Health, ZealandCharles P. Vega, MD
Clinical Professor, Family Medicine
University of California, Irvine School of Medicine
Orange, CADr. Vega has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Consulting Fees: Boehringer Ingelheim, GlaxoSmithKline
Reviewers/Content Planners/Authors:
- Cindy Davidson has no relevant relationships to disclose.
- Kathleen Sheridan, PhD, has no relevant relationships to disclose.
- Brian P. McDonough, MD, FAAFP, has no relevant relationships to disclose.
Learning Objectives
After participating in this educational activity, participants should be better able to:
- Assess the chronic and progressive nature of obesity and its impact on long-term health outcomes necessitating ongoing treatment
- Implement standardized diagnostic criteria and coding for obesity in clinical practice
- Develop personalized, long-term obesity management plans integrating lifestyle, behavioral, and evidence-based pharmacological interventions
- Collaborate effectively within multidisciplinary teams for comprehensive obesity care
- Utilize effective shared decision-making strategies to answer patient questions and collaboratively develop personalized management plans for patients with obesity, considering their individual needs, preferences, and values
Target Audience
This activity has been designed to meet the educational needs of primary care physicians and endocrinologists as well as all other physicians, physician assistants, nurse practitioners, nurses, pharmacists, and healthcare providers involved in managing patients with obesity.
Accreditation and Credit Designation Statements
In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
The American Medical Association has an agreement of mutual recognition of continuing medical education (CME) credits with the European Union of Medical Specialists (UEMS), the accreditation body for European countries. Physicians interested in converting AMA PRA Category 1 Credit(s)TM to UEMS-European Accreditation Council for Continuing Medical Education CME credits (ECMECs) should contact the UEMS at mutualrecognition@uems.eu.
Global Learning Collaborative (GLC) designates this enduring activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Global Learning Collaborative (GLC) designates this activity for 1.25 nursing contact hour(s). Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Global Learning Collaborative (GLC) designates this activity for 1.25 contact hour(s)/0.125 CEUs of pharmacy contact hour(s).
The Universal Activity Number for this program is JA0006235-0000-24-166-H01-P. This learning activity is knowledge-based. Your CE credits will be electronically submitted to the NABP upon successful completion of the activity. Pharmacists with questions can contact NABP customer service (custserv@nabp.net).Global Learning Collaborative (GLC) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit(s) for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.25 AAPA Category 1 CME credit(s). Approval is valid until January 31, 2026. PAs should claim only the credit commensurate with the extent of their participation in the activity.
Provider(s)/Educational Partner(s)
Prova Education designs and executes continuing education founded on evidence-based medicine, clinical need, gap analysis, learner feedback, and more. Our mission is to serve as an inventive and relevant resource for clinical content and educational interventions across a broad spectrum of specialties. Prova Education's methodology demonstrates a commitment to continuing medical education and the innovative assessment of its effects. Our goal is clear—to develop and deliver the best education in the most impactful manner and to verify its results with progressive outcomes research.Commercial Support
This activity is supported by an independent educational grant from Lilly USA, LLC.
Disclaimer
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Prova Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to access a site outside of Prova Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.
Reproduction Prohibited
Reproduction of this material is not permitted without written permission from the copyright owner.
System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date:
Expiration Date: Ongoing Program - Expiration date will be posted when all episodes are published.